, Volume 257, Issue 9, pp 1421-1431
Date: 22 May 2010

Neurological adverse events associated with anti-tumor necrosis factor alpha treatment

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Anti-tumor necrosis factor alpha (TNF-α) drugs have been successfully used for the treatment of rheumatic autoimmune diseases including rheumatoid arthritis (RA), psoriatic arthritis, psoriasis, ankylosing spondylitis (AS), juvenile chronic arthritis, and Crohn’s disease. However, they have been associated with different neurological disorders, including alterations of peripheral nerves, multiple sclerosis (MS), optic neuritis (ON) and acute transverse myelitis (ATM). This article reviews the most current aspect regarding neurological adverse events associated with anti-TNF-α drugs with emphasis on the possible explanations for this relation and the pathogenic mechanism of TNF-α in neurological disorders.